Skip to content Skip to footer

Surge in Awareness and Need Bolsters the Global Hospital-Acquired Infection Control Market towards a Projected $25 Billion by 2030

The Hospital-Acquired Infection Control Market – a field comprising of various products, services, and technologies designed to mitigate and control infections contracted by patients in healthcare settings – continues to show positive growth. The market incorporates a plethora of products including sterilization equipment, disinfectants, and protective gear, as well as consultation and other services geared towards infection prevention and containment. Antibiotic-resistant infections, the increasing cognizance of infection control significance, and the mounting healthcare expenses linked with these infections are potent drivers causing the hospital-acquired infection control market to accelerate. Precise data indicates a rise from a valuation of $19.95 billion in 2020 to a projected $25.00 billion by 2030, with a CAGR of 4.6% from 2022 to 2030. The escalating prevalence of chronic diseases, imminent threats of pandemic or epidemic outbreaks, and the rise in hospital-acquired infections are further fueling this industry’s growth.

However, potential drawbacks are the lethal effects of chemical disinfectants. Yet, fresh opportunities are expected to arise in developing countries given the market’s high potential. Amidst the Covid-19 pandemic, manufacturers of hospital-acquired infection control goods have ramped up production of critical medical nonwovens like gowns, masks, and gloves. The fearful rise in Covid-19 cases and the heightened need to protect healthcare personnel project a significant increase in demand for barrier protection products and disposable hospital supplies. Furthermore, the increased hospital surgeries and the necessity to prevent cross-contamination in clinics denote further increase in demand for sterilization and cleaning products. Out of all the products and services, the protective barriers segment claimed the largest market share in 2020, holding more than three-fourths of the global market.

With noted increases in surgeries, public awareness of personal hygiene, and Covid-19 cases, the demand for medical nonwovens such as surgical drapes, face masks, and gowns has rocketed. Conversely, the sterilization segment is expected to see the grandest CAGR of 5.9% between 2022 and 2030 due to the rise in outsourcing of sterilization services and chronic illnesses, the return of ethylene oxide sterilization, and increased levels of hospital-acquired infections. In terms of end-users, hospitals and clinics took the lion’s share in 2020, a trend predicted to continue. The dominating factors driving this includes the elevated volume of surgical procedures in these institutions, the rise of chronic diseases in the ageing population, and the proliferation of hospitals & clinics globally. Despite North America holding the largest market share in 2020, Asia-Pacific is slated for the fastest CAGR by 2030 due to advancement of personal hygiene, upsurge in trained medical professionals, favourable healthcare reimbursements, and increasing surgical procedures.


Sign Up to Our Newsletter

Be the first to know the latest updates

[yikes-mailchimp form="1"]